MetaCap

Climb Bio Insider Trades

NASDAQ: CLYMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.09+0.23 (+2.12%)

Market open · Delayed 15 min · as of Oct 9, 2:26 PM ET

Last 12 months

Purchases
3 · $779.63K
Sales
6 · $2.65M
Shares bought / sold
321.67K / 280.90K
Net activity
Net selling $1.9 million

Climb Bio insider activity

Over the last 12 months, Climb Bio insiders reported 15 transactions on SEC Form 4: 3 open-market purchases and 6 sales. Insiders bought $779,626 and sold $2.7 million worth of stock, for net insider selling of $1.9 million. The largest seller was Thomas Stephen Basil, with $2.2 million in reported sales.

The most recent filing shows RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund II, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M. (Director) reporting a transaction in 10,000 shares at $3.46 on Sep 28, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CLYM's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CLYM insider transactions

Climb Bio insider transactions
DateInsiderTypeSharesValueFiling
Sep 28, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund II, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorOption exercise40,000$51.60KForm 4
Sep 28, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund II, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorOption exercise10,000$78.90KForm 4
Sep 28, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund II, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorOption exercise10,000$30.00KForm 4
Sep 28, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund II, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorOption exercise10,000$34.60KForm 4
Sep 15, 2026Thomas Stephen BasilDirectorSale100,000$1.37MForm 4
Jun 29, 2026Brennan AoifePresident and CEOSale30,902$406.98KForm 4
Jun 27, 2026Brennan AoifePresident and CEOOption exercise68,750—Form 4
Feb 26, 2026Thomas Stephen BasilDirectorSale16,313$114.29KForm 4
Feb 25, 2026Thomas Stephen BasilDirectorSale33,687$235.96KForm 4
Feb 13, 2026Thomas Stephen BasilDirectorSale10,000$58.14KForm 4
Feb 12, 2026Thomas Stephen BasilDirectorSale90,000$470.99KForm 4
Jan 5, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund II, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy7,111$24.89KForm 4
Dec 12, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund II, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy101,462$290.18KForm 4
Dec 11, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund II, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy213,099$464.56KForm 4
Dec 11, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & RA Capital Nexus Fund II, L.P. & RA Capital Nexus Fund III, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorDisposition20,440,000—Form 4
Aug 7, 2025Thomas Stephen BasilDirectorAward100,375—Form 4
Jun 30, 2025Brennan AoifePresident and CEOSale20,618$25.15KForm 4
Jun 27, 2025Brennan AoifePresident and CEOOption exercise68,750—Form 4
Jun 27, 2025Thomas Stephen BasilDirectorOption exercise25,094—Form 4
Jun 20, 2025Pimblett EmilySVP, Finance & CAOSale1,242$1.54KForm 4
Jun 18, 2025Pimblett EmilySVP, Finance & CAOOption exercise5,000—Form 4
Mar 27, 2025Thomas Stephen BasilDirectorOption exercise25,093—Form 4
Mar 20, 2025Pimblett EmilySVP, Finance & CAOSale1,199$1.57KForm 4
Mar 18, 2025Pimblett EmilySVP, Finance & CAOOption exercise5,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related